Lazarini, Françoise
Levivien, Sarah
Madec, Yoann
Taieb, Fabien
Mottez, Estelle
Buivan, Tan-Phuc
Maudoux, Audrey
Wiener-Vacher, Sylvette
Nevoux, Jérôme
Van Den Abbeele, Thierry
Gressens, Pierre
Lledo, Pierre-Marie
Teissier, Natacha
Funding for this research was provided by:
Institut Pasteur (GPF 2015 Microbes, Brain “INFECSMELL”)
inserm
universite de paris
Article History
Received: 13 October 2021
Revised: 3 January 2022
Accepted: 4 January 2022
First Online: 14 January 2022
Declarations
:
: This study was performed in line with the principles of the declaration of Helsinki. Ethics approval (No. 3372) was received from Comité de Protection des Personnes (CPP IDF-3). All participants gave consent prior to beginning the study.
: All authors named consent to the publication of this manuscript.
: The odorant mixtures are the subject of a patent (WO2017198816A1 published on November 23, 2017) by Institut Pasteur, Centre National de la Recherche Scientifique, and Assistance Publique–Hôpitaux de Paris on which Drs Lazarini, Lledo, Teissier, and Levivien are named as inventors. Drs Lazarini, Madec, Taieb, Mottez, Lledo, and Mr Buivan are employees of Institut Pasteur of Paris that sponsored this research. The remaining authors declare no other disclosures.
Free to read: This content has been made available to all.